Johnson & Johnson will stop selling talc-based baby powder globally in 2023, the drugmaker said on Thursday, more than two years after it ended US sales of a product that drew thousands of consumer ...

J&J stock -- up 6 percent for the year -- plunged 11 percent on news of the report, based on memos, internal documents and confidential memos that the maker of Johnson's Baby Powder had been compelled ...

New research published this week lends credence to the more than 50,000 lawsuits against Johnson & Johnson that allege its talc-based baby powder caused ovarian cancer. The analysis, released ...

(Reuters) - Johnson & Johnson will stop selling talc-based baby powder globally in 2023, the drugmaker said on Thursday, more than two years after it ended U.S. sales of a product that drew thousands ...

Healthcare company Johnson & Johnson announced Thursday that it will no longer globally produce or distribute its talcum powder. The company will instead produce a corn starch powder beginning in 2023 ...

A Johnson & Johnson unit working to resolve massive cancer litigation in bankruptcy court was accused by a former head of the US Food and Drug Administration of making misleading claims that the ...

Johnson & Johnson on Tuesday announced it would stop selling its talc Baby Powder in the United States and Canada, saying demand had dropped in the wake of what it called “misinformation” about the ...

A unit of Johnson & Johnson (NYSE:JNJ) formed to handle the tens of thousands of talc-related litigation against it has sued several researchers over a study published that linked talcum powder use to ...

A Reuters examination of many of those documents, as well as deposition and trial testimony, shows that from at least 1971 to the early 2000s, the company’s raw talc and finished powders sometimes ...